CHL Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:01 am

Competitors of CHL Ltd

All Competitor Stocks of CHL Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:32 am

Below is a detailed analysis of the quarterly data for CHL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 35.21 Cr.. The value appears to be declining and may need further review. It has decreased from 39.11 Cr. (Dec 2024) to 35.21 Cr., marking a decrease of 3.90 Cr..
• For Expenses, as of Mar 2025, the value is 28.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.52 Cr. (Dec 2024) to 28.99 Cr., marking an increase of 1.47 Cr..
• For Operating Profit, as of Mar 2025, the value is 6.22 Cr.. The value appears to be declining and may need further review. It has decreased from 11.59 Cr. (Dec 2024) to 6.22 Cr., marking a decrease of 5.37 Cr..
• For OPM %, as of Mar 2025, the value is 17.67%. The value appears to be declining and may need further review. It has decreased from 29.63% (Dec 2024) to 17.67%, marking a decrease of 11.96%.
• For Other Income, as of Mar 2025, the value is 4.31 Cr.. The value appears strong and on an upward trend. It has increased from 3.16 Cr. (Dec 2024) to 4.31 Cr., marking an increase of 1.15 Cr..
• For Interest, as of Mar 2025, the value is 5.46 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.71 Cr. (Dec 2024) to 5.46 Cr., marking a decrease of 0.25 Cr..
• For Depreciation, as of Mar 2025, the value is 3.37 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.23 Cr. (Dec 2024) to 3.37 Cr., marking an increase of 0.14 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 5.81 Cr. (Dec 2024) to 1.70 Cr., marking a decrease of 4.11 Cr..
• For Tax %, as of Mar 2025, the value is 171.18%. The value appears to be increasing, which may not be favorable. It has increased from 56.97% (Dec 2024) to 171.18%, marking an increase of 114.21%.
• For Net Profit, as of Mar 2025, the value is -1.21 Cr.. The value appears to be declining and may need further review. It has decreased from 2.51 Cr. (Dec 2024) to -1.21 Cr., marking a decrease of 3.72 Cr..
• For EPS in Rs, as of Mar 2025, the value is -0.22. The value appears to be declining and may need further review. It has decreased from 0.46 (Dec 2024) to -0.22, marking a decrease of 0.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:39 am

Growth

Last Updated: September 5, 2025, 2:56 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for CHL Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -1.24. This value is below the healthy minimum of 5. It has decreased from 1.14 (Mar 24) to -1.24, marking a decrease of 2.38.
• For Diluted EPS (Rs.), as of Mar 25, the value is -1.24. This value is below the healthy minimum of 5. It has decreased from 1.14 (Mar 24) to -1.24, marking a decrease of 2.38.
• For Cash EPS (Rs.), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 3. It has decreased from 4.93 (Mar 24) to 2.07, marking a decrease of 2.86.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -22.08. It has decreased from -12.88 (Mar 24) to -22.08, marking a decrease of 9.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -22.08. It has decreased from -12.88 (Mar 24) to -22.08, marking a decrease of 9.20.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 27.08. It has increased from 24.59 (Mar 24) to 27.08, marking an increase of 2.49.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.29. This value is within the healthy range. It has decreased from 11.02 (Mar 24) to 8.29, marking a decrease of 2.73.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.91. This value is within the healthy range. It has decreased from 7.83 (Mar 24) to 5.91, marking a decrease of 1.92.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.62. This value is within the healthy range. It has decreased from 3.07 (Mar 24) to 1.62, marking a decrease of 1.45.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.31. This value is below the healthy minimum of 2. It has decreased from 1.74 (Mar 24) to -0.31, marking a decrease of 2.05.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.60. This value is below the healthy minimum of 2. It has decreased from 2.57 (Mar 24) to 1.60, marking a decrease of 0.97.
• For PBDIT Margin (%), as of Mar 25, the value is 30.62. This value is within the healthy range. It has decreased from 44.80 (Mar 24) to 30.62, marking a decrease of 14.18.
• For PBIT Margin (%), as of Mar 25, the value is 21.82. This value exceeds the healthy maximum of 20. It has decreased from 31.83 (Mar 24) to 21.82, marking a decrease of 10.01.
• For PBT Margin (%), as of Mar 25, the value is 5.97. This value is below the healthy minimum of 10. It has decreased from 12.49 (Mar 24) to 5.97, marking a decrease of 6.52.
• For Net Profit Margin (%), as of Mar 25, the value is -1.15. This value is below the healthy minimum of 5. It has decreased from 7.05 (Mar 24) to -1.15, marking a decrease of 8.20.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 5.90. This value is below the healthy minimum of 8. It has decreased from 10.43 (Mar 24) to 5.90, marking a decrease of 4.53.
• For Return on Networth / Equity (%), as of Mar 25, the value is -7.24. This value is below the healthy minimum of 15. It has increased from -12.24 (Mar 24) to -7.24, marking an increase of 5.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.93. This value is within the healthy range. It has decreased from 21.72 (Mar 24) to 16.93, marking a decrease of 4.79.
• For Return On Assets (%), as of Mar 25, the value is 2.46. This value is below the healthy minimum of 5. It has decreased from 4.13 (Mar 24) to 2.46, marking a decrease of 1.67.
• For Long Term Debt / Equity (X), as of Mar 25, the value is -2.00. This value is below the healthy minimum of 0.2. It has increased from -2.17 (Mar 24) to -2.00, marking an increase of 0.17.
• For Total Debt / Equity (X), as of Mar 25, the value is -2.00. This value is within the healthy range. It has increased from -2.17 (Mar 24) to -2.00, marking an increase of 0.17.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.42. It has increased from 0.40 (Mar 24) to 0.42, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1.5. It has increased from 0.35 (Mar 24) to 0.41, marking an increase of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.36, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.62. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 16.62, marking an increase of 16.62.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. It has decreased from 2.32 (Mar 24) to 1.93, marking a decrease of 0.39.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.97. This value is below the healthy minimum of 3. It has decreased from 1.37 (Mar 24) to 0.97, marking a decrease of 0.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 447.04. It has decreased from 454.13 (Mar 24) to 447.04, marking a decrease of 7.09.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.01. This value exceeds the healthy maximum of 3. It has decreased from 3.37 (Mar 24) to 3.01, marking a decrease of 0.36.
• For EV / EBITDA (X), as of Mar 25, the value is 9.83. This value is within the healthy range. It has increased from 7.52 (Mar 24) to 9.83, marking an increase of 2.31.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.34, marking a decrease of 0.03.
• For Price / BV (X), as of Mar 25, the value is -1.65. This value is below the healthy minimum of 1. It has decreased from -1.60 (Mar 24) to -1.65, marking a decrease of 0.05.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.37 (Mar 24) to 1.34, marking a decrease of 0.03.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.04, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness